<DOC>
	<DOCNO>NCT00454961</DOCNO>
	<brief_summary>The purpose clinical trial ass effectiveness artemether-lumefantrine ( Coartem® ) treatment provide community health worker uncomplicated malaria child 5 year age Kibaha District , Tanzania , extend follow-up 42 day . The hypothesis artemether-lumefantrine treatment provide community health worker result less 85 % PCR-corrected parasitological effectiveness day 42 , mainly due partial non-compliance full standard 6-dose regimen drug .</brief_summary>
	<brief_title>Effectiveness Artemether-Lumefantrine Malaria Treatment Children Community Level Tanzania</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<criteria>1 . Aged &lt; 5 year 2 . Weight &gt; 5 kg 3 . Suffering acute uncomplicated P. falciparum malaria confirm RDT . Later microscopy use Giemsastained thick film make ensure asexual parasite density 2000 200 000 parasites/µL 4 . Having history fever precede 24 h 5 . Able ingest tablet orally 6 . Willing able attend stipulate followup visit 7 . With write informed consent parent/guardian child participate trial . Presenting follow `` danger sign severe malaria '' : 1 . Convulsions ( &gt; 1 episode within previous 24 hour ) 2 . Lethargic/unconscious</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Malaria</keyword>
	<keyword>Plasmodium falciparum</keyword>
	<keyword>artemether-lumefantrine</keyword>
	<keyword>effectiveness</keyword>
</DOC>